Page Contents
Beyond Raw Chemistry Labs Nootropic review summary
This review examines the older Beyond Raw Chemistry Labs Nootropic formula recorded in our archive. Its specific focus is extract percentages, N-acetyl-tyrosine and a microgram huperzia entry. The historical label and analysis below are not a claim that every current bottle has this composition, and this review does not infer that the product has been discontinued.
Formula analysis: Extract percentages, N-acetyl-tyrosine and a microgram huperzia entry
The archived powder formula listed 1.5 g acetyl-L-tyrosine, 320 mg Synapsa Bacopa, 100 mg theanine and several other ingredients. Its 100 mg TeaCrine entry was described as 40% theacrine, yielding 40 mg. Material weight and active content should not be conflated.
The huperzia entry is even more sensitive to units: the archive recorded 100 micrograms of material standardized to 1%, yielding 1 microgram huperzine A. That is the arithmetic of the transcription, not confirmation that the transcription matches the package. It must not be silently read as 100 micrograms of active huperzine A or 100 mg of extract.
The earlier as-needed exam-performance verdict also combined different time courses. Repeated-dose Bacopa research does not establish an immediate all-nighter rescue, and acetyl-L-tyrosine does not automatically reproduce L-tyrosine studies. A coffee-fruit biomarker claim is not a direct cognitive result.
Archived ingredient table
The following is the original article’s historical transcription. Serving amounts, percentages, spelling and ingredient descriptions may reflect an older label or transcription errors. It is retained for formula comparison, not as current-use instructions. Historical Daily Values are not recalculated here.
Specific label limitation: Huperzia material/active microgram entry requires confirmation; no silent conversion to mg or to active huperzine A.
Beyond Raw Chemistry Labs Nootropic Ingredients | |
| Ingredients | Amount Per Serving |
| Tyrosine (as Acetyl L-Tyrosine) | 1.5 g |
| Synapsa™ Bacopa Leaf Extract (Bacopa monnieri) (Standardized to 50% Bacosides = 160mg) | 320 mg |
| TeaCrine® Theacrine (Standardized to 40% = 40 mg) | 100 mg |
| Suntheanine® L-Theanine | 100 mg |
| NeuroFactor™ Coffee Fruit Concentrate (Coffea arabica) (Standardized to 40% Total Polyphenols = 40 mg, 14% 5-Caffeoylquinic Acid = 14 mg & 1.5% Trigonelline = 1.5 mg) | 100 mg |
| Gamma-Aminobutyric Acid (GABA) | 50 mg |
| Rhodiola Root Extract (Rhodiola rosea) (Standardized to 3% Rosavins = 1.5 mg) | 50 mg |
| Huperzia Leaf Extract (Huperzia serrata) (Standardized to 1% Huperzine A = 1 mcg) | 100 mcg |
Safety and suitability
Theacrine and other active ingredients mean that caffeine-free wording, if used on a package, would not establish absence of stimulant-like effects or interaction concerns. Do not increase servings to compensate for a small amount of another ingredient.
What the evidence does not establish
Ingredient studies, manufacturer descriptions and customer reviews cannot demonstrate the effect of this complete formula. We have not established a controlled clinical trial of this exact archived formulation in this review. No hands-on testing, clinical credentials or laboratory verification by Nootropic Geek are claimed.
Verdict on the recorded formula
This archive is most useful as a careful exercise in ingredient form and unit interpretation. It does not support a reliable clutch-performance guarantee, and the huperzia transcription should be verified before a current-use decision.
Historical prices, stock statements and refund or subscription terms have been removed because they are not verified current offers. Before comparing value, establish the exact current formula, serving size and total purchase terms.
Related ingredient and comparison guides
- L-Tyrosine Review: Performance Under Stress and Evidence Limits
- Bacopa Monnieri Review: Memory Trials, Extracts and Limitations
- Huperzine A Review: Cholinesterase Inhibition and Mixed Evidence
Sources
- Original Nootropic Geek article snapshot: historical formula transcription and previous review context; not a current manufacturer label.
- Human multitasking study; supports a conditional working-memory claim rather than broad enhancement.
- Primary 12-week randomized Bacopa trial in healthy participants.
- Original retention-of-new-information study; distinguishes retention from all-domain improvement.
- Primary 210-participant phase II trial; prespecified primary endpoint did not demonstrate efficacy.
Nootropic Geek is an affiliate publishing brand. This is an editorial review, not individual medical advice. About Nootropic Geek.
